期刊名称：ANTIOXIDANTS & REDOX SIGNALING
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Antioxidants & Redox Signaling is a bimonthly, international, interdisciplinary peer-reviewed publication that encompasses the emerging field of antioxidants and redox biology. The Journal welcomes original contributions dealing with all aspects of reactive species, antioxidants and other redox-dependent process in biological and related systems. The Journal features basic as well as clinical research papers, brief communications of outstanding interest, review articles and commentaries. In addition, the Journal will publish relevant meeting abstracts, point/counterpoint, and News and Comments, including ongoing development of bench and clinical protocols, regulations, meeting announcements, industrial news, patents, publication announcements, and book reviews.
Indexed in Index Medicus/MEDLINE, EMBASE/Excerpta Medica, Science Citation Index-Expanded, ISI Alerting Services.
Instructions to Authors
ANTIOXIDANTS & REDOX SIGNALING (ARS; www.liebertpub.com/ars) is an international, interdisciplinary peer-reviewed publication that encompasses the emerging field of antioxidants and redox biology. The Journal is publishedbimonthly and is available both in print and online.
ARS welcomes original contributions dealing with all aspects of reactive species, antioxidants, and other redox-dependent processes in biological and related systems. The Journal features basic as well as clinical research papers, brief communications of outstanding interest, reviews, and commentaries. In addition, the Journal will publish relevant meeting abstracts, point/counterpoint, and news and comments, including ongoing development of bench and clinical protocols, regulations, meeting announcements, industrial news, patents, publication announcements, and book reviews.
Manuscript submission should be accompanied by a cover letter signed by all authors stating:
1. whether the submitted article is intended to be published as an original research communication, review, commentary, rapid letter, editorial, or news.
2. that the manuscript is not currently under consideration elsewhere and the work reported will not be submitted for publication elsewhere until a final decision has been made as to its acceptability by the Journal (posting of submitted material on a Web site is considered prior publication)
3. that the manuscript is truthful original work
4. that each author has made important scientific contribution to the study to warrant authorship and that each author is thoroughly familiar with primary data
5. that each author take responsibility for the content and completeness of the manuscript
6. names of two Executive Editors/Editors-in-Chief and four reviewers (preferably editorial board members) who, in the authors' opinion, may be most suited to evaluate the paper. The names of the editorial board members may be seen at the Journal website at www.liebertpub.com/ars
SUBMISSION
Three complete sets of hard copies and a disk copy (PC-compatible MS-WORD) should be submitted to the new ARS CENTRAL EDITORIAL OFFICE, LABORATORY OF MOLECULAR MEDICINE/CMIS, 512 DAVIS HEART & LUNG RESEARCH INSTITUTE, THE OHIO STATE UNIVERSITY MEDICAL CENTER, 473 WEST 12TH AVENUE, COLUMBUS, OHIO 43210; Tel.: 614-247-7658 (Dr. Sen); 614-247-7786 (office); fax: 614-247-7818; e-mail: sen-1@medctr.osu.edu
Electronic submission: To ensure an expedited peer review process, authors are strongly encouraged to submit the manuscript and all related illustrations as ONE Adobe PDF file. The file, with active Save and Print functions, should be electronically mailed to sen-1@medctr.osu.edu. Such submission should not be instead of submitting the hard copies as indicated above. Note that submission of such PDF file should be done in addition to submitting the three hardcopies and an MS-Word disk copy as indicated above. Importantly, the entire content (text, references, all illustrations) of a manuscript should be enclosed in no more than one PDF file. The file should be named as ARS_fisherab_093001 where Dr. A.B. Fisher is the corresponding author of a manuscript submitted on September 30, 2001.
To submit any review paper or commentary, or any material for the news and comments section, please contact the ARS Central Editorial Office in advance.
RETURN OF SUBMITTED MATERIAL
Material submitted to ARS for publication will not be returned to the authors. An exception to this policy may be made if the corresponding author and the ARS Central Editorial Office agree to do so at the time of first manuscript submission. In that case, the corresponding author should request for a written agreement from the ARS Central Editorial Office and retain that document. Claim to return submitted material such as illustrations and glossies should be made to the ARS Central Editorial Office no later than one week after final editorial decision has been communicated to the author.
PREPARATION OF MANUSCRIPT
Type the entire manuscript including figure legends, tables, and references double-spaced on regular typewriter paper (not erasable bond). Leave ample margins on both sides, top and bottom (1.5 inches).
Length: Manuscripts should be written succinctly and should cite select references that are directly relevant. RAPID LETTERS should not exceed a total of 3,000 words including a maximum of 25 references; ORIGINAL RESEARCH COMMUNICATIONS should not exceed a total of 5,000 words including a maximum of 50 references; REVIEWS should not exceed a total of 7,500 words including a maximum of 100 references. Exceptional cases, where these restrictions may have to be reconsidered, should be discussed with the Central Editorial Office before submission of the manuscript.
The title page should have the title of the paper; author(s); department and institution in which the work was done, with city, state, or country, and zip code; an abbreviated title for the running head (not exceeding 55 characters including spaces between words); name and address for mailing proofs; and a contact telephone, fax number, and e-mail address. Where necessary, identify each author's affiliation by superscript numbers matched to the appropriate institution. On top of the title page indicate the type of intended publication, e.g., Original Research, Rapid Letter, Commentary, Review, etc.
On the second page, supply an abstract of no more than 200 words, stating the Aims, Results, and Conclusions drawn from the study. This should be followed by the Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, tables, and figure legends.
Results and Discussion must be separate sections. Begin each of these sections on a separate page.
A complete list of abbreviations arranged in alphabetical order must be provided.
Number pages (bottom-center) consecutively; the first author's last name should appear on each page.
The source of cells utilized (species, sex, strain, race, age of donor, whether primary or established) should be clearly indicated. The source of reagents should be stated (name, city, and state within parentheses) when first cited. Publication of results is based on the principle that results must be verifiable. Authors are expected to make unique reagents available to qualified investigators either directly or through a recognized distributor. The text should be clear and concise, conforming to accepted standards of English style and usage. Unfamiliar or new terms should be defined when first used (see section on Abbreviations, Symbols, and Terminology). Jargon, clichés, and laboratory slang should not be used.
The Journal welcomes original contributions dealing with all aspects of reactive species, antioxidants, and other redox-dependent processes in biological and related systems. Because a primary objective of the Journal is to illuminate the role of reactive species, antioxidants, and other redox sensitive processes in regulating cellular signal transduction pathways, authors are encouraged to put their results into perspective in the Discussion section. This can be accomplished by including a brief (250 words or less) Perspectives section in the last paragraph of the Discussion. The Perspectives section should be clearly labeled with a separate heading. In this section, authors of manuscripts that do not directly relate to cell signaling are encouraged to discuss and even speculate how findings of their study may be extended to understand the regulation of cellular signaling pathways. The discussion/hypothesis/speculation should be well supported by a referenced rationale. This section should be able to provide impetus for future work directly related to cell signaling. The Perspectives section should NOT replace the conclusion drawn from the study and must be limited to one paragraph.
RAPID LETTER
The Rapid Letters track aims at expediting publication of short communications of outstanding significance. Editorial decision is guaranteed within four weeks from the date of receipt as confirmed by the editorial office. If the corresponding author does not receive the review report within three weeks of the date of receipt, they are encouraged to contact the editorial office. Manuscripts in this track will be either accepted directly or rejected. There will be no provision for revision. Once accepted, Rapid Letters will not be listed in the queue of manuscripts waiting to be published. The communication will be published in the very next issue going to press.
A Rapid Letter will report material of outstanding interest and will be peer reviewed more rigorously and promptly compared to other forms of publication in ARS. A decision to reject will not be supported by a detailed review report. The communication should be divided as follows: Abstract (no more than 150 words), Introduction, Materials and Methods, Results and Discussion, Acknowledgments, Abbreviations, References, Tables, and Figure legends. The whole report should be composed of no more than four journal pages (no more than 3,000 words), including tables, figures and references. The reference list should contain no more than 20 references. For general rules please follow the guidelines given for regular papers.
ETHICS OF EXPERIMENTATION
The Journal endorses the principles embodied in the Declaration of Helsinki and insists that all investigations involving humans be conducted in conformity with these principles. All animal experimentation reported must be conducted in conformity with internationally accepted principles. In describing surgical procedures, the type and dosage of the anesthetic agent should be specified. Curarizing agents are not anesthetics; if these were used, evidence must be provided that anesthesia of suitable grade and duration was employed. Editors are expected to refuse papers in which evidence of the adherence to these principles is not apparent. They reserve the right to judge the appropriateness of the use of animals and humans in experiments published in the journals. The Editors-in-Chief will adjudicate differences of opinion.
ABBREVIATIONS, SYMBOLS, AND TERMINOLOGY
Include in the manuscript a list of new or special abbreviations used in the paper, with the spelled-out form of the definition. Internationally accepted biochemical abbreviations such as ADP, NADH, and pi do not need to be defined; other frequently used abbreviations need only to be defined at first mention. For commonly accepted abbreviations, word usage, symbols, etc., authors are referred to Scientific Style and Format: The CBE Manual for Authors, Editors, and Publishers (6th ed., 1994). Chemical and biochemical terms and abbreviations should be in accordance with the recommendations of the IUPAC-IUB Combined Commission on Biochemical Nomenclature. Isotope specification should conform to the IUPAC system.
SPELLING AND COMPOUNDING
Authors should follow Webster's Third New International Dictionary for spelling and compounding.
PROMISSORY NOTES
Journal policy is against inclusion of implicit or explicit promises that future work will be published.
TABLES AND ILLUSTRATIONS
Each figure should be presented in its final size. The size should be kept to a minimum and unnecessary use of space must be avoided. Single column wide illustrations should not exceed 7.5 cm in width. Use Times New Roman with font-size no smaller than 6. It is strongly recommended that this format be used to present standard data. Manuscripts that do not meet this requirement will be administratively rejected. For illustrations that must be wider, the maximum limit is 15 cm for width. Submission of color illustrations indicates that the cooresponding author accepts to cover additional printing charges.
Type each table double-spaced with a brief title on a separate sheet of paper. The title should be brief and informative. All explanatory matter including explanation of abbreviations should be in footnotes, not in the title. Horizontal and vertical lines should be omitted. Use Arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences. Table footnotes should be listed in order of their appearance and identified by standard symbols *, ? ? ?for four or fewer; for five or more, use consecutive superior letters.
PHOTOGRAPHS
Glossies must be submitted for photomicrographs, gels, and other halftones. Photocopies of line drawings are acceptable at submission as long as two sets of high-quality camera copy are provided when the manuscript is accepted; for computer-generated laser prints, use paper recommended for camera-ready copy or back up on zip disks such as an EPS or TIFF file. Reviewers are not required to return manuscripts but will be asked to return halftones if that is requested by the authors at the time of submission. DNA sequence data may be submitted as glossy photos but will be accepted as computer print-outs provided a letter-quality laser printer (not a dot matrix printer) is used. All nucleic acid sequences must be submitted in camera-ready format and will not be typeset. All illustrations should be numbered and bear the first author's name on the back. The top of the illustration should be indicated. A legend should be supplied for each illustration, and all legends numbered consecutively and typed (double-spaced). Figures should be numbered in the order cited in the text. A complete, separately collated set should be submitted with each copy of the manuscript. Figure legends should describe experimental conditions and all abbreviations used. Electrocardiograms, kymograms, and oscillograms should be prepared so that the crosshatched background is eliminated. To avoid problems in processing, use non-photo, blue-ruled instead of black-ruled, recording paper for the originals.
COLOR REPRODUCTION
The Journal will publish color photographs, but the author will be charged for the cost of color separations and printing at the rate of $275 per piece of color art plus $1,200 per page of color. The publisher will provide the author with a more precise cost estimate when the figures are received. For further details, contact the ARS Central Editorial Office or the Publisher.
ABSTRACTS
Each paper should have an abstract of no longer than 200 words. Submissions with longer abstracts will not be considered for publication.
REFERENCE STYLE
Authors are responsible for the accuracy of citations. References must be limited to directly pertinent published works or papers that have been accepted for publication.
An abstract properly identified (Abstract) may be cited only when it is the sole source. Submitted papers can be cited in the text as "unpublished observations" and should not be included in the reference list.
References should be double-spaced (do not single-space any line), arranged alphabetically by author, and numbered serially. The reference number should be placed in parentheses at the proper point in the text. Example: Oxidants serve as cellular messengers (1-3). The style of citation should be as follows, with the journal name abbreviated as in Index Medicus.
Journal papers. Example: 1. Moldovan L, Irani K, Moldovan NI, Finkel T, and Goldschmidt-Clermont PJ. The actin cytoskeleton reorganization induced by Rac1 requires the production of superoxide. Antiox Redox Signal 1: 29-43, 1999.
Book References. Author(s); title of book (main words capitalized); city of publication; publisher; year; and pages. Example: 2. Sen CK, Sies H, and Baeuerle PA (Eds). Antioxidant and Redox Regulation of Genes. San Diego, CA: Academic Press, 2000, p. 562.
Book Section References. Example: 3. Masutani H, Ueno M, Ueda S, and Yodoi J. Role of thioredoxin and redox regulation in oxidative stress response and signaling. In: Antioxidant and Redox Regulation of Genes, edited by Sen CK, Sies H, and Baeuerle PA. San Diego, CA: Academic Press, 2000, pp. 298-310.
Internet Citation for World Wide Web Home Page. Author/editor (if known). Revision or copyright date, if available. Title of page (publication medium). Page publisher. URL (Protocol:Site/Path/File). Access date. Example: Gene information search tool [Online]. Case Western Reserve University. http://genome.cwru.edu/gist/gist.html. 1999, Nov. 5.
References to government technical documents should be included only when their availability is ensured. For style of citation of these documents, congress proceedings, chapters in books, etc., consult recent issues of the journals.
Citations such as "unpublished observations" or "personal communication" should not be included in the reference list but may be added in parentheses in the text. It is assumed that in "personal communications" the author has secured the permission of the person cited.
DISK COPY
Authors are required to submit a disk copy containing the version of the manuscript that EXACTLY matches the submitted hard copy. Microsoft Office-related softwares are preferred.
PERMISSIONS
The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote to a reprinted table or to the legend of a reprinted figure should read, "Reprinted by permission from Jones et al.," and list the appropriate reference. All permissions listings must be shown in the manuscript - they cannot be entered on proofs. Manuscripts submitted to this Journal must not be under consideration elsewhere.
PAGE CHARGES
None.
REPRINTS
Reprints may be ordered by using the special reprint order form that will accompany the proofs. Reprints ordered after the issue is printed will be charged at a higher rate.
REJECTION WITHOUT REVIEW
Manuscripts that are not formatted strictly according to the guidelines described here may be rejected without any peer review.
The volume of manuscripts submitted for publication in ARS has markedly increased during the past year's time. Only manuscripts reflecting a high level of innovation will be accepted for publication. Other manuscripts will be rejected without detailed review comments.
PUBLISHER
ANTIOXIDANTS & REDOX SIGNALING is published by Mary Ann Liebert, Inc., 2 Madison Avenue, Larchmont, NY 10538. Tel: (914) 834-3100; fax: (914) 834-3771; e-mail: info@liebertpub.com
Editorial Board
Editors-In-Chief
Chandan K. Sen
The Ohio State University
Medical Center
Columbus, OH
sen-1@medctr.osu.edu
Dipak K. Das
University of Connecticut
School of Medicine
Farmington, CT
ddas@neuron.uchc.edu
Executive Editors
Enrique Cadenas
University of Southern California
cadenas@hs.usc.edu
Aron B. Fisher
University of Pennsylvania
Medical Center
abf@mail.med.upenn.edu
Pascal J. Goldschmidt-Clermont
Duke University Medical Center
golds017@mc.duke.edu
Kathy K. Griendling
Emory University School of Medicine
kgriend@emory.edu
Valerian Kagan
University of Pittsburgh
kagan@pitt.edu
Norbert Leitinger
University of Vienna, Austria
norbert.leitinger@univie.ac.at
Gregg L. Semenza
The Johns Hopkins University
gsemenza@welchlink.welch.jhu.edu
Makoto Suematsu
Keio University, Japan
msuem@sc.itc.keio.ac.jp
Junji Yodoi
Kyoto University, Japan
yodoi@virus1.virus.kyoto-u.ac.jp
Editorial Board
Bharat B. Aggarwal
M.D. Anderson Cancer Center
University of Texas
Angelo Azzi
Universitat Bern, Switzerland
Debasis Bagchi
Creighton University School of
Pharmacy and Allied Health
Professions, Omaha
Ivor J. Benjamin
University of Texas Southwestern Medical Center
Dallas
Eda T. Bloom
Food and Drug Administration
Rockville
Jeffrey Blumberg
USDA Human Nutrition Research
Center on Aging at Tufts, Boston
Wolf Bors
GSF Research Center
Neuherberg, Germany
Augustine M. Choi
University of Pittsburgh
An-Sik Chung
Korea Advanced Institute of Science
& Technology, South Korea
Hun-Taeg Chung
Wonkwang University School of
Medicine, Chonbug, South Korea
Joel DeLeiris
Universite Joseph Fourier de
Grenoble, France
Aubrey de Grey
University of Cambridge, UK
Wulf Droge
Deutsches Krebsforschungszentrum
Germany
John F. Engelhardt
University of Iowa
Iowa City
Toren Finkel
National Heart, Lung and Blood
Institute, Bethesda
Tory Hagen
Linus Pauling Institute
Corvallis
Barry Halliwell
The National University of
Singapore
Mark B.Hampton
Christchurch School of Medicine
New Zealand
Nikki J. Holbrook
National Institute of Aging
Bethesda
Arne Holmgren
Karolinska Institutet, Sweden
Kaikobad Irani
The Johns Hopkins University
Baltimore
Harry Ischiropoulos
Stokes Research Institute
Philadelphia
Sushil K. Jain
Louisiana State University
Shreveport
Anil K. Jaiswal
Baylor College of Medicine
Houston
Kuan-Teh Jeang
NIAID/NIH, Bethesda
George L. King
Harvard Medical School
Boston
Harry Lander
Cornell University Medical
College, New York
David J. Lefer
LSU Health Sciences Center in
Shreveport
Nilanjana Maulik
University of Connecticut
Farmington
Hasan Mukhtar
University of Wisconsin
Madison
Izumi Nakashima
Nagoya University, Japan
Takashi Okamoto
Nagoya City University
Medical School, Japan
Lester Packer
University of Southern California
Los Angeles
Sampath Parthasarathy
Emory University, Atlanta
George Perry
Case Western Reserve
University, Cleveland
Rajiv R. Ratan
Harvard Institutes of Medicine
Boston
Vijaylakshmi Ravindranath
National Brain Research Centre
Haryana, India
Michael B. Reid
Baylor College of Medicine
Houston
Sashwati Roy
The Ohio State University
Medical Center, Columbus
Gary Schieven
Bristol-Myers Squibb Research
Institute, Princeton
Helmut Sies
Heinrich-Heine-Universitat
Dusseldorf, Germany
Pawan K. Singal
St. Boniface Gen. Hosp.Research
Centre, Winnipeg, Canada
Ann Smith
University of Missouri-Kansas City
Raj S. Sohal
University of Southern California
Los Angeles
Daniel J. Steenkamp
University of Cape Town Medical
School, South Africa
Yuichiro J. Suzuki
USDA Human Nutrition Research
Center on Aging at Tufts, Boston
Naoyuki Taniguchi
Osaka University Medical
School, Japan
Dennis Templeton
University of Virginia Medical
School, Charlottesville
Oren Tirosh
The Hebrew University of
Jerusalem
Israel
Richard Weindruch
University of Wisconsin
Madison
Hirohei Yamamura
Kobe University, Japan
Toshikazu Yoshikawa
Kyoto Prefectural University of
Medicine, Japan
Seppo Yla-Herttuala
A.I.Virtanen Institute,
Kuopio, Finland
Jay L. Zweier
The Ohio State University, Columbus
|
刊名字顺( Alphabetical List of Journals):
返回页首 